Huge real-world data set confirms efficacy of Pfizer COVID-19 vaccine

The Israeli case-control study of 1.2 million people also finds no concerns with results in over-70s

A real-world test of Israel’s mass vaccination program shows that the Pfizer-BioNTech COVID-19 vaccine is highly effective at preventing death, severe illness and hospitalisations.

The 94% efficacy rate from the two-dose regimen, based on data from more than half a million vaccinated individuals in a case-control study, is consistent with findings from Pfizer’s phase III randomised controlled trial.

Israel’s vaccination program is the world’s most advanced in per capita administration of the vaccine,